祖睿股票讨论

$祖睿 (ZUO.US)$
上 ⬆️⬆️⬆️⬆️⬆️

祖睿的乐观未来前景还没有完全反映在其当前股价上。然而，它的高beta值表明，如果股价下跌，未来可能会有购买机会。

祖睿的股价最近有所改善，可能表明业务转型积极。然而，其长期表现更为重要，过去五年年均亏损约9%。在投资决策中应考虑祖睿的三个警示信号。

$祖睿 (ZUO.US)$ ??

$祖睿 (ZUO.US)$ 一家领先的基于云端的订阅管理平台，今天宣布与微软达成了多层协议，将几款微软产品与祖睿®进行集成。今天的公司正在寻求一种新的业务敏捷性，以部署新的业务模式，推出产品线并进行国际扩张。与此同时，他们需要他们的应用程序和平台帮助他们实现上市及之后的规模扩展。这些新的集成解决方案将为财务团队提供更多的灵活性，增强订阅分析功能，并使得从两家企业领导者那里部署和采用技术变得比以往任何时候都更容易。

$祖睿 (ZUO.US)$ , a leading cloud-based subscription management platform, today announced a multi-tiered agreement with Microsoft to integrate several Microsoft products with Zuora®.
Today’s companies are looking for a new level of business agility to deploy new business models, launch product lines, and expand internationally. At the same time, they need their applications and platforms to help them scale to IPO and beyond. These new integrated solutions will deliver finance teams more agility, power enhanced subscription analytics, and make it easier than ever to deploy and adopt technology from two enterprise leaders.

内部人士抛售股票：
$VIZIO (VZIO.US)$ 
$Fulgent Genetics (FLGT.US)$ 
$Cara Therapeutics (CARA.US)$ 
$KnowBe4 (KNBE.US)$ 
$Coursera (COUR.US)$ 
$Intellia Therapeutics (NTLA.US)$ 
$Natera (NTRA.US)$ 
$DraftKings (DKNG.US)$ 
$Natural Alternatives International (NAII.US)$ 
$Revolve Group (RVLV.US)$ 
$A10 Networks (ATEN.US)$ 
$祖睿 (ZUO.US)$内部买入 $Spero Therapeutics (SPRO.US)$ 
$Lumos Pharma (LUMO.US)$ 
$Oscar Health (OSCR.US)$ 
$Phibro Animal Health (PAHC.US)$